Retatrutide, from Soma Pharmaceuticals , represents a significant advance in body management . This innovative drug combines hormonal receptor properties with GIP pathway engagement, demonstrating substantial potential in trial data for metabolic improvement. Experts believe Retatrutide could provide a different solution for patients facing weight-